Position in ARVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,060,212
-$1,296,318 QoQ
Shares Held
247,920
-21.7% QoQ
Ownership
0.379%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 201 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. ARVN ranks #116 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in ARVN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,060,212 | 247,920 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,356,530 | 316,654 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $3,582,904 | 302,100 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $2,028,236 | 238,056 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,199,148 | 162,928 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $573,862 | 81,747 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $714,158 | 37,254 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $903,253 | 36,673 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $961,752 | 36,129 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,428,534 | 34,606 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $7,097,505 | 172,437 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $895,622 | 45,602 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,686,857 | 188,834 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,260,431 | 229,152 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $25,728,619 | 752,079 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $34,031,332 | 764,921 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $23,607,268 | 560,876 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $41,362,445 | 614,598 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $44,667,483 | 543,797 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $39,669,106 | 482,710 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $10,970,036 | 142,468 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $616,183 | 9,322 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $11,478,628 | 135,154 | Shares | Defined | 2021-02-16 | |
| 2020-06-30 | $577,491 | 17,218 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $4,166,696 | 103,392 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||